Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-06-18 13:53 CEST (UTC+2h)

Follow-up: It gets worse! [Off Topic]

posted by ElMaestro - Denmark, 2017-04-18 10:01  - Posting: # 17245
Views: 1,288

Hi all,

surely I am going to burn in hell for this but given how completely hopeless that invitation was I sent this response to the organisers:

Dear Ms. [name],

I would like to humbly thank you for your invitation to WGC-2017.

Would you be interested if I give a talk in Theme 801 with the title: "Genomics in the new millenium: The apparent inability of Sequential Bioequivalence Designs to address important contemporary DNA-related topics such as recombination rate in transposon-rich regions of Chromosome VI of the European honey bee (Apis mellifera)" ?

I look forward to receiving your response.


This morning their answer was in my inbox:

I appreciate your feedback and welcome you give an oral presentation in this conference. The organizing committee is very interested in your lecture title.

Secondly, at this moment, may I ask if you could give your lecture abstract along with biography to me? Please be sure that both of abstract & biography should be limited in One Page. (Follow the format I attached).Since these materials will be included in our meeting proceeding in the future, please be aware that total amount of the characters should not exceed 2500.
Since speech solts are limited, please register on http://www.bitcongress.com/wgc2017/OnlineRegistration.asp to confirm your participation firstly and send the abstract to me a little later.


This little story is in a sense a good image of the sad state of affairs science sometimes finds itself in. Money talks. Facts and reason don't.

if (3) 4

Best regards,
ElMaestro

"(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures." New York Times (ed.), June 9, 2018.

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,383 posts in 3,904 threads, 1,175 registered users;
online 32 (2 registered, 30 guests [including 9 identified bots]).

The art and science of asking questions
is the source of all knowledge.    Thomas Berger

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed